Overview of Sinalgico
Quick Facts
| Property | Description |
|---|---|
| Active Ingredient | Ketorolac tromethamine |
| Form | Tablets, Solution for Injection, Ophthalmic Solution |
| Pharmacological Class | Non-Steroidal Anti-Inflammatory Drug (NSAID) |
| Common Use | Short-term relief of moderate-to-severe acute pain |
| Origin | Synthetic compound |
1. The Definitive Classification of Sinalgico: An NSAID Analgesic
Sinalgico is the trade name for a potent pharmaceutical product whose active ingredient is Ketorolac tromethamine. This substance belongs to the core pharmacological group known as a Non-Steroidal Anti-Inflammatory Drug (NSAID), and is distinguished as a powerful systemic analgesic.
The active substance, Ketorolac, is a synthetic compound that is clinically recognized for its analgesic potency, often reserved for short-term situations where strong pain control is necessary. This classification sets it apart from common, over-the-counter NSAIDs, defining it as a specialized option for higher-intensity pain management. The Ketorolac entity's established role in medicine is confirmed by its inclusion on the World Health Organization (WHO) Model List of Essential Medicines.
2. Composition and Forms: Defining the Ketorolac Entity
The medicine is a single-ingredient product, with its therapeutic effect delivered solely by the Ketorolac tromethamine salt. Sinalgico is formulated in several specialized pharmaceutical preparations, including tablets for oral ingestion, a sterile solution for injection for parenteral administration, and an ophthalmic solution (eye drops) for localized ocular application.
This variety in dosage forms is a key feature, allowing healthcare professionals to select the most appropriate route of administration depending on the acute clinical requirement. For instance, the robust efficacy of the injectable form is recognized for its effectiveness in managing severe discomfort such as postoperative pain.
3. General Therapeutic Purpose of this Potent Analgesic
The overarching purpose of Sinalgico is to provide effective, short-term relief of moderate-to-severe acute pain by utilizing both its powerful analgesic and concurrent anti-inflammatory properties. This crucial dual action helps manage both the pain sensation and the underlying tissue response.
Its general benefit centers on achieving rapid and effective pain management in acute settings. This makes the Ketorolac entity particularly instrumental in situations where a patient requires decisive relief, such as managing pain following a surgical procedure.
Regulatory References
